Seres Therapeutics
MCRB
MCRB
93 hedge funds and large institutions have $50M invested in Seres Therapeutics in 2024 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 25 increasing their positions, 27 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
22% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 27
25% less capital invested
Capital invested by funds: $66.8M → $50M (-$16.7M)
33% less call options, than puts
Call options by funds: $319K | Put options by funds: $478K
Holders
93
Holding in Top 10
1
Calls
$319K
Puts
$478K
Top Buyers
| 1 | +$1.09M | |
| 2 | +$574K | |
| 3 | +$543K | |
| 4 |
Jane Street
New York
|
+$449K |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
+$227K |
Top Sellers
| 1 | -$3.66M | |
| 2 | -$3.2M | |
| 3 | -$1.58M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$1.16M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$1.12M |